 "RPG Life Sciences buys Sun Pharma's 7 brands for Rs 41 crore")
RPG Life Sciences Ltd has acquired seven brands of Sun Pharmaceuticals Industries and its subsidiary, for a consideration of Rs 41 crores. “The company today signed an agreement with RPG Life Sciences Ltd to divest seven prescription brands in India, owned by Sun Pharma and its subsidiary, for a consideration of Rs 41 crores,” said Sun Pharma in a press statement.
The seven divested products include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.
The divestment is subject to receipt of Competition Commission of India's (CCI) approval.
The seven divested products include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.
The divestment is subject to receipt of Competition Commission of India's (CCI) approval.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%